MedTrace Logo

GOLO Open-Label Pilot 1

NCT03478202 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2018-03-27

No results posted yet for this study

Summary

The objective of this open-label pilot study is to evaluate the effect of the commercially available GOLO for Life (GFL) weight management program on body weight in a type 2 diabetic patient population after approximately 3 months.

Conditions

  • Diabetes Mellitus, Type II

Interventions

DIETARY_SUPPLEMENT

GOLO RELEASE

GOLO RELEASE plus Diet

Sponsors & Collaborators

  • Golo

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2017-12-23
Completion
2017-12-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03478202 on ClinicalTrials.gov